D.C. Diagnosis: Trump negotiates drug prices, leaked MAHA report
President Trump may have the opportunity to benefit from a law passed by Democrats that allows Medicare to negotiate drug prices. This potential benefit for Trump was highlighted in a recent segment on Last Week Tonight with John Oliver, which discussed the MAHA movement and referenced an article by Sarah Todd titled “Why MAHA’s push on Coca-Cola and ice cream is ‘nutritionally hilarious.'”
The segment on Last Week Tonight can be viewed by following the link provided. Additionally, readers are encouraged to read Sarah Todd’s piece and can send news tips to the email address provided or contact John_Wilkerson.07 on Signal.
The focus of the article is on the question of whether President Trump will take a strong stance on Medicare drug price negotiation. Democrats have put in the effort to pass legislation allowing Medicare to negotiate drug prices, and Trump could potentially benefit from this policy change.
Unfortunately, the rest of the article is restricted to STAT+ subscribers. To access the full content and receive in-depth analysis, newsletters, premium events, and news alerts, readers are encouraged to subscribe to STAT+.
In conclusion, the article highlights the potential impact of Medicare drug price negotiation and the role that President Trump may play in this important issue. Readers are encouraged to stay informed by subscribing to STAT+ for exclusive access to premium content.
